danny, Author at Lucius Partners

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine

Collaboration aims to accelerate candidate development and animal model testing of HaloVax™ Self-Assembling Vaccine to fight Coronavirus COVID-19
Data on two candidates from both small […]

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccinedanny2023-04-14T21:57:19-04:00

HaloVax™ Announces Agreement with Hoth Therapeutics to Joint Develop a Self-Assembling Vaccine (SAV) to Protect Patients at Risk of Coronavirus (COVID-19) Infection

The Vaccine & Immunotherapy Center (VIC) at Massachusetts General Hospital will continue to work with HaloVax and Hoth to Advance this Project
Voltron Therapeutics, Inc., the […]

HaloVax™ Announces Agreement with Hoth Therapeutics to Joint Develop a Self-Assembling Vaccine (SAV) to Protect Patients at Risk of Coronavirus (COVID-19) Infectiondanny2020-03-27T12:54:30-04:00

Hoth, Voltron form Halovax to to find COVID-19 Vaccine

‘It’s an incredibly challenging time’: Hoth, Voltron form Halovax to find COVID-19 vaccine...

Hoth, Voltron form Halovax to to find COVID-19 Vaccinedanny2023-04-14T21:57:27-04:00

Agreement with Hoth Therapeutics

Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)...

Agreement with Hoth Therapeuticsdanny2020-03-24T19:55:29-04:00

About danny

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine

HaloVax™ Announces Agreement with Hoth Therapeutics to Joint Develop a Self-Assembling Vaccine (SAV) to Protect Patients at Risk of Coronavirus (COVID-19) Infection

HaloVax™ Announces Agreement with Hoth Therapeutics to Joint Develop a Self-Assembling Vaccine (SAV) to Protect Patients at Risk of Coronavirus (COVID-19) Infection

Hoth, Voltron form Halovax to to find COVID-19 Vaccine

Agreement with Hoth Therapeutics